Marta Bellini
Ospedale Papa Giovanni XXIII(IT)Chiesi Foundation(IT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes(2013)576 cited
- → Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis(2014)381 cited
- → Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial(2021)126 cited
- → High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib(2021)80 cited
- → CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis(2014)71 cited
- → Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria(2017)60 cited
- → Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene(2015)60 cited
- → Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera(2023)46 cited
- → LNK mutations in familial myeloproliferative neoplasms(2016)44 cited
- → A novel germline JAK2 mutation in familial myeloproliferative neoplasms(2013)37 cited